The development of multiple bladder tumor recurrences in relation to the FGFR3 mutation status of the primary tumor

被引：0
|
作者：
Kompier, Lucie
van Tilborg, Angela
van der Aa, Madelon
Lurkin, Irene
Vermeij, Marcel
Kirkels, Wim
Bangma, Chris
van der Kwast, Theo
Zwarthoff, Ellen
机构：
[1] Erasmus MC, Dept Pathol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Urol, Rotterdam, Netherlands
[3] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1644
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Role of the FGFR3 gene mutation status in predicting progression of non- muscle-invasive bladder cancer
    Rolevich, A. I.
    Smal, M. P.
    Krasnyi, S. A.
    Goncharova, R. I.
    ONKOUROLOGIYA, 2015, 11 (03): : 62 - 70
  • [22] FGFR3 has tumor suppressor properties in cells with epithelial phenotype
    Marie Lafitte
    Isabelle Moranvillier
    Stéphane Garcia
    Evelyne Peuchant
    Juan Iovanna
    Benoit Rousseau
    Pierre Dubus
    Véronique Guyonnet-Dupérat
    Geneviève Belleannée
    Jeanne Ramos
    Aurélie Bedel
    Hubert de Verneuil
    François Moreau-Gaudry
    Sandrine Dabernat
    Molecular Cancer, 12
  • [23] Nonclinical activity of the FGFR, VEGFR and PDGFR inhibitor lucitanib in FGFR3 translocated tumor models
    Minh Nguyen
    Lin, Kevin K.
    Burbridge, Mike F.
    Simmons, Andrew D.
    Harding, Thomas C.
    CANCER RESEARCH, 2015, 75
  • [24] THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER
    van Rhijn, Bas W.
    Bostrom, Peter J.
    Shariat, Shahrokh F.
    Finelli, Antonio
    Sagalowsky, Arthur I.
    Fleshner, Neil E.
    Bapat, Bharati
    Kortekangas, Hannes
    Ashfaq, Raheela
    Mirtti, Tuomas
    Jewett, Michael A.
    Lotan, Yair
    van der Kwast, Theo H.
    Zlotta, Alexandre R.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E561 - E561
  • [25] THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER
    Van Rhijn, B. W. G.
    Bostrom, P. J.
    Shariat, S. F.
    Finelli, A.
    Sagalowsky, A., I
    Fleshner, N. E.
    Bapat, B.
    Kortekangas, H.
    Ashfaq, R.
    Mirtti, T.
    Jewett, M. A. S.
    Lotan, Y.
    Van Der Kwast, Th. H.
    Zlotta, A. R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 243 - 243
  • [26] Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
    Pouessel, D.
    Neuzillet, Y.
    Mertens, L. S.
    van der Heijden, M. S.
    de Jong, J.
    Sanders, J.
    Peters, D.
    Leroy, K.
    Manceau, A.
    Maille, P.
    Soyeux, P.
    Moktefi, A.
    Semprez, F.
    Vordos, D.
    de la Taille, A.
    Hurst, C. D.
    Tomlinson, D. C.
    Harnden, P.
    Bostrom, P. J.
    Mirtti, T.
    Horenblas, S.
    Loriot, Y.
    Houede, N.
    Chevreau, C.
    Beuzeboc, P.
    Shariat, S. F.
    Sagalowsky, A. I.
    Ashfaq, R.
    Burger, M.
    Jewett, M. A. S.
    Zlotta, A. R.
    Broeks, A.
    Bapat, B.
    Knowles, M. A.
    Lotan, Y.
    van der Kwast, T. H.
    Culine, S.
    Allory, Y.
    van Rhijn, B. W. G.
    ANNALS OF ONCOLOGY, 2016, 27 (07) : 1311 - 1316
  • [27] A bispecific antibody inhibits FGFR3 dimerization and is highly effective in FGFR3-driven tumor models
    Yang, Yan
    Avvaru, Naga Suhasini
    Jiang, Zaoli
    Liu, Nina
    Rosconi, Michael
    Zhang, Bojie
    Li, Yinyin
    Ullman, Erica
    Lin, John Chia-Yang
    Shen, Yang
    Daly, Christopher
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [28] FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population
    Bodoor, Khaldon
    Ghabkari, Abdulhameed
    Jaradat, Ziad
    AlKhateeb, Asem
    Jaradat, Saied
    Al-Ghazo, Mohammed A.
    Matalka, Ismail
    Musleh, Hisham
    Haddad, Yazan
    CANCER EPIDEMIOLOGY, 2010, 34 (06) : 724 - 732
  • [29] Multiple recurrences of unknown primary tumor in a meningioma: A case report
    Essibayi, Muhammed Amir
    Abdallah, Anas
    Ozek, Erdinc
    Coban, Ganime
    NEURORADIOLOGY JOURNAL, 2022, 35 (06): : 763 - 767
  • [30] FGFR3 Down-Regulation is Involved in bacillus Calmette-Guerin Induced Bladder Tumor Growth Inhibition
    Langle, Yanina V.
    Belgorosky, Denise
    McCormick, Barbara Prack
    Sahores, Ana
    Gongora, Adrian
    Baldi, Alberto
    Lanari, Claudia
    Lamb, Caroline
    Eijan, Ana M.
    JOURNAL OF UROLOGY, 2016, 195 (01): : 188 - 197
12345